aminaphthone

Known as: 1,4-dihydroxy-3-methyl-2-naphthyl 4-aminobenzoate, 3-methyl-1,2,4-naphthalenetriol-2-(4-aminobenzoate), aminaftone 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1978-2014
012319782014

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Prostaglandins appear to reduce biofilm formation and chronicization of infections, and stimulate a rapid and effective clearance… (More)
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
Review
2015
Review
2015
s from the 2015 American Venous Forum Annual Meeting Fig. Mean pressure in common femoral vein. Randomized Double-Blinded Study… (More)
Is this relevant?
2011
2011
Pulmonary hypertension is characterized by increased vascular resistances, that could lead to right heart failure and death… (More)
Is this relevant?
2008
2008
BACKGROUND Vasculopathy is one of the hallmarks of systemic sclerosis (SSc), characterized by endothelial activation and over… (More)
  • figure 1
  • figure 2
Is this relevant?
2008
2008
BACKGROUND AND OBJECTIVE Endothelin-1 (ET-1) plays a central role in the pathogenesis of several vascular diseases. Aminaftone is… (More)
Is this relevant?
2008
2008
The crystal structure of the title compound, C(18)H(13)NO(4), the oxidized form of the drug aminaftone used in venous disease… (More)
  • table 1
  • figure 1
  • figure 2
Is this relevant?
Review
2005
Review
2005
BACKGROUND Chronic venous insufficiency (CVI) is a common condition caused by inadequate blood flow through the veins, usually in… (More)
  • figure 1
  • figure 3
  • figure 4
  • figure 5
  • figure 6
Is this relevant?
1989
1989
Following a short introduction on the physiopathology of the phlebo-lymphatic system, the results of a study carried out on 114… (More)
Is this relevant?